期刊文献+

Diagnosis and Treatment of Malignant Tumors Using Integrated Traditional and Western Medicine:Progress,Challenges and Reflections 被引量:1

Diagnosis and Treatment of Malignant Tumors Using Integrated Traditional and Western Medicine:Progress,Challenges and Reflections
原文传递
导出
摘要 Malignant tumors are one of the leading causes of death in the world. Considerable progresses have been made on the treatment of tumors in recent decades, especially in the prevention, early diagnosis and the model changing of therapeutics. But we are still facing tough challenges, including the increasing treatment burden and limited improvement of efficacy. In China, Chinese medicine (CM) provides a powerful arsenal to fight against tumors. CM can be well applied to the onset and progression of tumors in China, bearing the characteristics of multi-target, multi-phase and multi-effect. But there are also many problems demanding urgent attention in the use of CM. Some most debated problems in this field were summarized. We should upgrade our concepts in using CM, find its position scientifically, and establish evidence of its effect by high quality clinical research. Malignant tumors are one of the leading causes of death in the world. Considerable progresses have been made on the treatment of tumors in recent decades, especially in the prevention, early diagnosis and the model changing of therapeutics. But we are still facing tough challenges, including the increasing treatment burden and limited improvement of efficacy. In China, Chinese medicine (CM) provides a powerful arsenal to fight against tumors. CM can be well applied to the onset and progression of tumors in China, bearing the characteristics of multi-target, multi-phase and multi-effect. But there are also many problems demanding urgent attention in the use of CM. Some most debated problems in this field were summarized. We should upgrade our concepts in using CM, find its position scientifically, and establish evidence of its effect by high quality clinical research.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2012年第5期333-338,共6页 中国结合医学杂志(英文版)
关键词 malignant tumors Chinese medicine integrated traditional and Western medicine malignant tumors, Chinese medicine, integrated traditional and Western medicine
  • 相关文献

参考文献4

二级参考文献70

  • 1高勇,石昭泉,曹传武,朱长力,郭静.泰索帝联合顺铂及健择联合顺铂治疗非小细胞肺癌随机对照临床研究[J].癌症,2005,24(8):985-989. 被引量:19
  • 2肖景榕,陈建顺,周衍,陈礼慈,吴晶萍.1989-1998年长乐市10409例恶性肿瘤生存率分析[J].中国慢性病预防与控制,2005,13(5):225-227. 被引量:17
  • 3陈建国,朱健,张永辉.启东市1972~2000年主要恶性肿瘤生存率分析[J].中国肿瘤,2006,15(9):575-578. 被引量:33
  • 4Ohuchida K,Mizumoto K, Yamada D, et al. Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer [ J ]. Clin Cancer Res ,2006,12 (7 Pt 1 ) : 2066 - 2069.
  • 5Lee EJ, Gusev Y, Jiang J, et al. Expression profiling identifies microRNA signature in pancreatic cancer[ J ]. lnt J Cancer,2007,120 (5): 1046 - 1054.
  • 6Wang J,Chen J,Chang P,et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood - based biomarkers of disease [ J ]. Cancer Prey Res ( Phila Pa), 2009,2 ( 9 ) : 807 - 813.
  • 7Ho AS, Huang X, Cao H, et ah Circulating miR -210 as a Novel Hypoxia Marker in Pancreatic Cancer [ J ]. Transl Oncol, 2010,3 (2): 109 -113.
  • 8Gronborg M, Kristiansen TZ, Iwahori A, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach[ J]. Mol Cell Proteomics,2006,5 ( 1 ) : 157 - 171.
  • 9Shen J, Person MD ,Zhu J, et al. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two - dimensional gel electrophoresis and mass spectrometry [ J ]. Cancer Res, 2004,64 (24) : 9018 -9026.
  • 10Brat D J, Lillemoe KD, Yeo C J, et al. Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas[ J]. Am J Surg Pathol, 1998,22(2 ) : 163 - 169.

共引文献75

同被引文献16

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部